Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Research Council grant · Running

InFibrosis Early Inflammation in Fibrotic Niches of Chonic Kidney Disease

Coordinator
Universite Paris Cite, France
Runs
1 January 2027 to 31 December 2031
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101302838

What the project is doing

In the project's own words, from its summary on CORDIS.

Chronic kidney disease (CKD) affects more than 10% of the global population and remains a major unmet medical challenge. Fibrosis, the hallmark of CKD, develops in spatially restricted microenvironments known as fibrogenic niches, where immune and stromal cells engage in reciprocal communication that sustains myofibroblast activation and progressive tissue scarring. However, the early inflammatory events that initiate these niches—particularly the dialogue between macrophages and fibroblasts—remain poorly understood.

InFibrosis aims to decipher how inflammation triggers fibrogenic niche formation in the kidney. The project combines human biopsy cohorts, spatial analysis, and innovative experimental systems to link molecular mechanisms with disease prognosis. Specifically, I will (i) develop histology-based prognostic markers identifying inflammatory zones predictive of CKD progression; (ii) dissect macrophage–stromal crosstalk driving fibroblast activation using advanced in vitro techniques and single-cell analyses, including the first human “niche-in-a-dish” model that reproduces the inflammatory microenvironment leading to fibrosis; and (iii) identify and functionally test druggable pathways capable of disrupting these pathogenic circuits.

By integrating clinical, histological, and mechanistic approaches, InFibrosis will redefine our understanding of how inflammation shapes fibrosis in early CKD. The expected outcomes include predictive tools for patient stratification and novel therapeutic targets that pave the way toward interventions modulating cell–cell communication to prevent chronic kidney disease progression.

Who is involved

OrganisationCityCountryRole
Universite Paris CiteParisFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI